TY - JOUR
T1 - Auto-segmentation of pelvic organs at risk on 0.35T MRI using 2D and 3D Generative Adversarial Network models
AU - Vagni, Marica
AU - Tran, Huong Elena
AU - Romano, Angela
AU - Chiloiro, Giuditta
AU - Boldrini, Luca
AU - Zormpas Petridis, Konstantinos
AU - Kawula, Maria
AU - Landry, Guillaume
AU - Kurz, Christopher
AU - Corradini, Stefanie
AU - Belka, Claus
AU - Indovina, Luca
AU - Gambacorta, Maria Antonietta
AU - Placidi, Lorenzo
AU - Cusumano, Davide
PY - 2024
Y1 - 2024
N2 - Purpose: Manual recontouring of targets and Organs At Risk (OARs) is a time-consuming and operator-dependent task. We explored the potential of Generative Adversarial Networks (GAN) to auto-segment the rectum, bladder and femoral heads on 0.35T MRIs to accelerate the online MRI-guided-Radiotherapy (MRIgRT) workflow. Methods: 3D planning MRIs from 60 prostate cancer patients treated with 0.35T MR-Linac were collected. A 3D GAN architecture and its equivalent 2D version were trained, validated and tested on 40, 10 and 10 patients respectively. The volumetric Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff Distance (HD95th) were computed against expert drawn ground-truth delineations. The networks were also validated on an independent external dataset of 16 patients. Results: In the internal test set, the 3D and 2D GANs showed DSC/HD95th of 0.83/9.72 mm and 0.81/10.65 mm for the rectum, 0.92/5.91 mm and 0.85/15.72 mm for the bladder, and 0.94/3.62 mm and 0.90/9.49 mm for the femoral heads. In the external test set, the performance was 0.74/31.13 mm and 0.72/25.07 mm for the rectum, 0.92/9.46 mm and 0.88/11.28 mm for the bladder, and 0.89/7.00 mm and 0.88/10.06 mm for the femoral heads. The 3D and 2D GANs required on average 1.44 s and 6.59 s respectively to generate the OARs’ volumetric segmentation for a single patient. Conclusions: The proposed 3D GAN auto-segments pelvic OARs with high accuracy on 0.35T, in both the internal and the external test sets, outperforming its 2D equivalent in both segmentation robustness and volume generation time.
AB - Purpose: Manual recontouring of targets and Organs At Risk (OARs) is a time-consuming and operator-dependent task. We explored the potential of Generative Adversarial Networks (GAN) to auto-segment the rectum, bladder and femoral heads on 0.35T MRIs to accelerate the online MRI-guided-Radiotherapy (MRIgRT) workflow. Methods: 3D planning MRIs from 60 prostate cancer patients treated with 0.35T MR-Linac were collected. A 3D GAN architecture and its equivalent 2D version were trained, validated and tested on 40, 10 and 10 patients respectively. The volumetric Dice Similarity Coefficient (DSC) and 95th percentile Hausdorff Distance (HD95th) were computed against expert drawn ground-truth delineations. The networks were also validated on an independent external dataset of 16 patients. Results: In the internal test set, the 3D and 2D GANs showed DSC/HD95th of 0.83/9.72 mm and 0.81/10.65 mm for the rectum, 0.92/5.91 mm and 0.85/15.72 mm for the bladder, and 0.94/3.62 mm and 0.90/9.49 mm for the femoral heads. In the external test set, the performance was 0.74/31.13 mm and 0.72/25.07 mm for the rectum, 0.92/9.46 mm and 0.88/11.28 mm for the bladder, and 0.89/7.00 mm and 0.88/10.06 mm for the femoral heads. The 3D and 2D GANs required on average 1.44 s and 6.59 s respectively to generate the OARs’ volumetric segmentation for a single patient. Conclusions: The proposed 3D GAN auto-segments pelvic OARs with high accuracy on 0.35T, in both the internal and the external test sets, outperforming its 2D equivalent in both segmentation robustness and volume generation time.
KW - 0.35T MR-Linac
KW - Adaptive MRI-guided Radiotherapy
KW - Automatic segmentation
KW - Generative Adversarial Networks
KW - Prostate cancer
KW - 0.35T MR-Linac
KW - Adaptive MRI-guided Radiotherapy
KW - Automatic segmentation
KW - Generative Adversarial Networks
KW - Prostate cancer
UR - http://hdl.handle.net/10807/303999
U2 - 10.1016/j.ejmp.2024.103297
DO - 10.1016/j.ejmp.2024.103297
M3 - Article
SN - 1120-1797
VL - 119
SP - N/A-N/A
JO - Physica Medica
JF - Physica Medica
ER -